Kane Biotech Inc.
KNBIF
$0.0328
$0.005520.15%
OTC PK
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 1.18M | 343.40K | 249.40K | 403.00K | 737.90K |
Total Receivables | 102.00K | 141.90K | 61.20K | 582.50K | 320.30K |
Inventory | 245.30K | 109.60K | 261.30K | 509.50K | 531.70K |
Prepaid Expenses | 220.10K | 306.10K | 143.10K | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | 142.70K | 122.00K |
Total Current Assets | 1.75M | 901.10K | 715.10K | 1.64M | 1.71M |
|
|||||
Total Current Assets | 1.75M | 901.10K | 715.10K | 1.64M | 1.71M |
Net Property, Plant & Equipment | 626.50K | 627.70K | 645.80K | 714.90K | 731.60K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 417.90K | 388.60K | 372.60K | 538.20K | 533.10K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 2.79M | 1.92M | 1.73M | 2.89M | 2.98M |
|
|||||
Total Accounts Payable | 760.80K | 667.40K | 824.40K | 517.80K | 373.30K |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | 6.00K | 5.90K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 390.00K | 330.90K | 320.90K | 331.80K | 318.00K |
Total Finance Division Other Current Liabilities | 303.70K | 602.30K | 529.70K | 1.19M | 1.38M |
Total Other Current Liabilities | 303.70K | 602.30K | 529.70K | 1.19M | 1.38M |
Total Current Liabilities | 1.45M | 1.60M | 1.67M | 2.04M | 2.08M |
|
|||||
Total Current Liabilities | 1.45M | 1.60M | 1.67M | 2.04M | 2.08M |
Long-Term Debt | 1.00M | 601.40K | 666.00K | 776.30K | 830.20K |
Short-term Debt | -- | -- | -- | 6.00K | 5.90K |
Capital Leases | 508.70K | 504.20K | 524.90K | 581.30K | 595.40K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 2.97M | 2.71M | 2.87M | 3.40M | 3.50M |
|
|||||
Common Stock & APIC | 26.20M | 23.99M | 22.74M | 24.11M | 23.28M |
Retained Earnings | -26.38M | -24.79M | -23.92M | -24.67M | -23.91M |
Treasury Stock & Other | 10.60K | 10.10K | 45.70K | 48.70K | 102.70K |
Total Common Equity | -172.30K | -789.00K | -1.13M | -509.70K | -527.30K |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -172.30K | -789.00K | -1.13M | -509.70K | -527.30K |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -172.30K | -789.00K | -1.13M | -509.70K | -527.30K |
|